BAYER HEALTHCARE AG
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- May 31, 2016 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,222 Total Citation Count
- Aug 23, 1978 Earliest Filing
- 196 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2003/0022,283 Neuropeptide Y receptor Y5 and nucleic acid sequencesDec 20, 01Jan 30, 03[C07H, C12P, C12N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7858394 Test methods for determining the intracellular concentration of cyclic nucleotidesMar 06, 04Dec 28, 10[G01N]
7258971 Methods and compositions for treating urological disorders using carboxypeptidase Z identified as 8263Jan 14, 04Aug 21, 07[C12Q]
7063951 Members of the capsaicin/vanilloid receptor family of proteins and uses thereofJun 02, 00Jun 20, 06[G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8501755 Tetrahydropyridothienopyrimidine compounds and methods of use thereofExpiredMar 20, 07Aug 06, 13[A61K, C07D]
8431695 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseasesExpiredNov 02, 06Apr 30, 13[A61K, C07D, A61P]
2010/0129,321 DIARYL UREA FOR TREATING VIRUS INFECTIONSAbandonedDec 06, 06May 27, 10[A61K, C07D, A61P]
2010/0105,090 SECRETED LUCIFERASE MLUC7 AND USE THEREOFAbandonedJan 26, 08Apr 29, 10[C07H, C12Q, C12N, A01K, C07K]
2010/0048,641 Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating DiseasesAbandonedFeb 16, 07Feb 25, 10[A61K, C07D, A61P]
2010/0016,299 Substituted benzoxepino-isoxazoles and use thereofAbandonedJun 28, 07Jan 21, 10[A61K, C07D, A61P]
2009/0288,658 Antibiotic Formulations, Unit Doses, Kits, and MethodsAbandonedDec 22, 08Nov 26, 09[A61K, C07G, A61M]
2009/0258,877 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USEAbandonedDec 12, 08Oct 15, 09[A61K, C07D, A61P]
7589195 Tetrahydrobenzo[d]azepin-2-one derivatives and the use thereof for treating cardiovascular diseasesWithdrawnFeb 01, 05Sep 15, 09[A61K, C07D]
2009/0136,920 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)AbandonedApr 18, 05May 28, 09[C07H, C12Q, C12N, G01N, C07K]
2009/0082,328 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityAbandonedMay 09, 08Mar 26, 09[A61K, C07D, C07C, A61P]
2009/0023,753 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic AgentsAbandonedFeb 24, 06Jan 22, 09[A61K, C07D, A61P]
2008/0286,260 Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)AbandonedMar 11, 05Nov 20, 08[A61K, C12Q, G01N, A61P]
7449198 Stable salts of O-acetylsalicylic acid with basic amino acidsExpiredAug 09, 04Nov 11, 08[A61K]
2008/0255,202 Phenylthioacetic Acid Derivatives and Use ThereofAbandonedMar 26, 05Oct 16, 08[A61K, C07D, A61P]
2008/0248,462 Diagnostics and Therapeutics for Diseases Associated with Arginyl Aminopeptidase (Aminopeptidase B)-Like 1 (Rnpepl1)AbandonedOct 12, 04Oct 09, 08[C07H, C12Q, G01N, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
